0.63 ML lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML Injection
SCD
4
These highlights do not include all the information needed to use OTARMENI safely and effectively. See full prescribing information for OTARMENI. OTARMENI™ (lunsotogene parvec-cwha) suspension, for intracochlear infusion Initial U.S. Approval: 2026
lunsotogene parvec-cwha 3.0 x 10(13) vg/ML in 0.63 ML Injection
PSN
4
These highlights do not include all the information needed to use OTARMENI safely and effectively. See full prescribing information for OTARMENI. OTARMENI™ (lunsotogene parvec-cwha) suspension, for intracochlear infusion Initial U.S. Approval: 2026
lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES per 0.63 ML Injection
SY
4
These highlights do not include all the information needed to use OTARMENI safely and effectively. See full prescribing information for OTARMENI. OTARMENI™ (lunsotogene parvec-cwha) suspension, for intracochlear infusion Initial U.S. Approval: 2026